A Conversation with Scott Gottlieb, M.D.
The Impact of Health Care Reform on Access to Biologics, Health Policy, and Managed Care

Read the article in full as an Adobe Acrobat PDF

Scott Gottlieb, MD, is one busy guy. One day he's putting the finishing touches on a policy paper for the American Enterprise Institute, the nonpartisan conservative think tank where he is a resident fellow. The next day he's testifying before Congress about Medicare costs. And the day after that, he's off to New York to fulfill his duty as an internist at NYU's Tisch Hospital. Then it's a red-eye to California for a meeting at Combimatrix, where he's on the board of directors, followed by a flight back to Washington, during which he's cranking out an op-ed piece for the Wall Street Journal.

Such is the life of a man who, at age 39, has achieved more than most people do in a lifetime. Since earning his MD at Mt. Sinai School of Medicine in 1999, Gottlieb has become a leading expert on health policy, regulation, and technology-due in part to his service in various capacities deep within our country's healthcare policymaking apparatus. From 2005 to 2007, he was deputy commissioner for Medical and Scientific Affairs at the U.S. Food and Drug Administration -the FDA's No. 2 job-prior to that, he served as a senior policy adviser at the Centers for Medicare and Medicaid Services, where he was instrumental in the development of Medicare Part D. He also has had consulting roles with several biotech and pharmaceutical companies. Gottlieb is a charter member of the editorial board of Biotechnology Healthcare.

Yet, for all his influence, Gottlieb presents himself with grace and humility. Five minutes into our conversation, Gottlieb asks, "Am I rambling?"

It took Biotechnology Healthcare about seven weeks to catch up with Gottlieb, and we think it was worth the chase. In a wide-ranging interview with senior contributing writer Michael D. Dalzell, Gottlieb shares his thoughts on healthcare reform and its effects on health policy, biologics, and managed care.

Scott Gottlieb, M.D., is a resident fellow at AEI

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Scott
Gottlieb
  • Scott Gottlieb, M.D., a practicing physician, has served in various capacities at the Food and Drug Administration, including senior adviser for medical technology; director of medical policy development; and, most recently, deputy commissioner for medical and scientific affairs. Dr. Gottlieb has also served as a senior policy adviser at the Centers for Medicare & Medicaid Services. 

    Click here to read Scott’s Medical Innovation blog.


    Follow Scott Gottlieb on Twitter.

  • Phone: 202.862.5885
    Email: scott.gottlieb@aei.org
  • Assistant Info

    Name: Kelly Funderburk
    Phone: 202.862.5920
    Email: Kelly.Funderburk@AEI.org

What's new on AEI

image The Census Bureau and Obamacare: Dumb decision? Yes. Conspiracy? No.
image A 'three-state solution' for Middle East peace
image Give the CBO long-range tools
image The coming collapse of India's communists
AEI on Facebook
Events Calendar
  • 21
    MON
  • 22
    TUE
  • 23
    WED
  • 24
    THU
  • 25
    FRI
Wednesday, April 23, 2014 | 12:00 p.m. – 1:30 p.m.
Graduation day: How dads’ involvement impacts higher education success

Join a diverse group of panelists — including sociologists, education experts, and students — for a discussion of how public policy and culture can help families lay a firmer foundation for their children’s educational success, and of how the effects of paternal involvement vary by socioeconomic background.

Thursday, April 24, 2014 | 12:00 p.m. – 1:30 p.m.
Getting it right: A better strategy to defeat al Qaeda

This event will coincide with the release of a new report by AEI’s Mary Habeck, which analyzes why current national security policy is failing to stop the advancement of al Qaeda and its affiliates and what the US can do to develop a successful strategy to defeat this enemy.

Friday, April 25, 2014 | 9:15 a.m. – 1:15 p.m.
Obamacare’s rocky start and uncertain future

During this event, experts with many different views on the ACA will offer their predictions for the future.   

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled today.
No events scheduled this day.